Innovation that delivers better outcomes. 20+ years of continuous innovation, experience, and proven results you can count on. Innovation that delivers better outcomes. 20+ years of continuous innovation, experience, and proven results you can count on.

We work every day to give you and your patients the best Wearable Cardioverter Defibrillator (WCD) experience so that you can focus on better outcomes. Our push for continued innovation never stops. Explore all the reasons to choose LifeVest:

Icon - LifeVest Garment

Next Generation LifeVest Garment:
Lightweight, Discreet, and Breathable

Man putting on LifeVest garment

Preferred by patients
for comfort

Compared to the previous LifeVest garment1

Man putting on LifeVest garment

ZOLL has improved LifeVest design multiple times over the last 20+ years, leading to a median real-world Wear Time®

23.4 hours/day2

Meet the new LifeVest garment >

Icon AI-Enhanced

AI-Enhanced Algorithm:
Advanced Arrhythmia Discrimination (AArD)

With AArD, the majority of LifeVest patients experience

ZERO
FALSE
ALARMS

AT 90 DAYS3

Two women facing camera, one with yellow shirt and one with blue dress and LifeVest

Starting in 2018, ZOLL has used AI-based AArD technology to filter out non-physiological electrocardiogram (ECG) signals, reducing an already low rate of false alarms. Research published in 2023 validates LifeVest is smarter than ever.

View the data on 96,000 patients >

 

icon - AI Enhanced

 

Icon proven outcomes
Icon proven outcomes

Peer Reviewed Evidence.
Better Outcomes.

With 20+ years of clinical evidence, LifeVest is the ONLY WCD proven to reduce mortality in a randomized controlled trial (RCT).

75%

REDUCTION

in mortality at 90 days in patients who wore LifeVest.4

90%

ONE-YEAR SURVIVAL

in patients who experience ventricular tachycardia/ventricular fibrillation (VT/VF).5

Icon - Patient Engagement

Patient Engagement App:
Education, Data, & Support During Recovery

The LifeVest Patient App helps patients get the most out of their LifeVest experience.

Track progress with access to their own Wear Time (R) and Activity data. On-demand device education, success stories, and support resources - all at your patients' fingertips. Track progress with their own Wear Time (R) and Activity Data. On-demand device education, success stories, and support resources - all at your patients' fingertips.
Icon patient engagement

Icon ECG Classifier
Icon ECG Classifier

ECG Classifier:
See Actionable Arrhythmias

Developed with machine learning, LifeVest ECG Classifier filters out noise and identifies arrhythmias that may require intervention — from ablation to implantable cardioverter defibrillator (ICD).

1 IN 14
PATIENTS

experience an actionable arrhythmia during LifeVest use.6

Icon 14 patients with one highlighted

 

HIGHLY ACCURATE,
FDA-APPROVED

CLASSIFICATION OF ECGs
that may require clinical intervention.7

Icon target

 

 

Icon - National Patient Access

Access for All: Broadest WCD Coverage + Options for Uninsured

For 20+ years, ZOLL has built positive payer relationships, turnkey authorization procedures, and access programs. Trust ZOLL to minimize reimbursement hiccups.

100% of Medicare Part B plans cover LifeVest & > 95% of people in the US have in-network coverage A range of financial plans and programs provide access options for uninsured and underinsured patients 100% of Medicare Part B Plans cover LifeVest and greater than 95% of people in the US have in-network coverage A range of financial plans and programs provide access options for uninsured and underinsured patients

Talk to a product expert to review your patients' options >


Icon national patient access

 

Icon Trusted Support

Trusted Support:
The Largest, Most Experienced WCD Support Team

Image of medical professional and patient, both smiling. Medical professional has arm around patient.

Trust your patients with the
team that has supported

1M+ LIFEVEST PATIENTS

Image of medical professional and patient, both smiling. Medical professional has arm around patient.

Your patients have access to in-person representatives with extensive care experience, and a reliable, multilingual support team that can be reached 24/7.

 

Contact your ZOLL Cardiac Management Solutions representative.

Learn more about how 20+ years of continued innovation, experience, and proven results makes LifeVest the WCD solution you can count on.

References

  1. Data on file, 20c1184_a01. Garment Comparative Wear Test.
  2. Data on file, 90d0258_a01. 2021 Commercial Compliance Analysis.
  3. Arkles J, Delaughter C, D’Souza B. A novel artificial intelligence based algorithm to reduce wearable cardioverter-defibrillator alarms. J Interv Cardiac Electrophysiol. 2023. https://doi.org/10.1007/s10840-023-01497-w
  4. Olgin JE, Lee BK, Vittinghoff E, et al. Impact of wearable cardioverter-defibrillator compliance on outcomes in the VEST trial: As-treated and per-protocol analyses. J Cardiovasc Electrophysiol 2020;1–10. https://doi.org/10.1111/jce.14404
  5. Kutyifa V, Moss A, Klein H, et al. One-year follow-up of the prospective registry of patients using the wearable defibrillator (WEARIT-II Registry). Pacing Clin Electrophysiol. 2018;1–7. https://doi.org/10.1111/pace.13448
  6. Kutyifa V, Moss A J, Klein H, et al. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: Data from the prospective registry of patients using the wearable cardioverter defibrillator (WEARIT-II Registry). Circulation 2015;132(17):1613–1619.
  7. Pre-clinical test data on file at ZOLL as of July 2020.